ENDOREV: A Solution to Reduce Anxiety During Gynecological Consultations in Patients With Suspected Endometriosis? (ENDOREV)
The aim of the research is to evaluate the effectiveness of virtual reality on the anxiety of patients with suspected endometriosis in gynecological consultation.
Indeed, several studies prove that patients in this situation are anxious. We would like to offer help in reducing anxiety in this case by means of digital therapy.
As part of this study, the equipment used will be "Bliss DTX". This is a non-drug digital therapy (digital therapeutics) already used in various hospital departments.
Bliss DTX immerses patients in sound and image programs scientifically developed for their effect on pain and anxiety, mobilizing their abilities and placing them in an altered state of consciousness. Bliss DTX software is delivered to patients via a dedicated video headset (virtual reality) and audio headset, as part of an integrated solution.
Conduct of the study:
The patient will be taken care of on the day of the consultation by a clinical research nurse. It will be installed in a reception room in the consultation room. The nurse will give him a questionnaire on anxiety to complete before the consultation.
A draw will be carried out with two options:
- Bliss DTX digital therapy via audio and video headphones lasting 13 minutes
- Installation in the reception room while waiting for the doctor to arrive. After the consultation, the patient will complete a new questionnaire on her state of anxiety and her feelings during the consultation.
A telephone call will be made 6 months after the consultation to collect post-consultation information.
Duration :
Duration of 6 months on 46 patients followed for 18 months. Expected benefits
- Reduction of anxiety after consultation by diversion of attention
- Strengthening the bond of trust between the patient and the care team
- Better monitoring and better compliance with treatment and medical examinations
- Better pain management
- Improved quality of life
Possible side effects:
No particular risks or constraints, however, a virtual reality headset can cause symptoms such as: nausea, dizziness, sweating, paleness, balance disorders grouped under the term "cybernetosis" as well as epileptic seizures in people. subjects predisposed to convulsions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Title :
ENDOREV: A solution to reduce anxiety during gynecological consultations in patients with suspected endometriosis?
Description of the study :
Single-center, randomized, controlled, open-label interventional study on two parallel groups Study composed of 46 patients randomized into two groups A and B with a ratio of 1:1 Experimental Group A: The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes Group B control: The patient will be seated and wait for the doctor to arrive (no material) The duration of inclusion is 18 months and individual participation is 6 months, that is to say 24 months for the entire study.
Completion of the questionnaire (IASTA Y-1) for both groups before the consultation and data collection.
Filling of the CRF in consultation by the doctor Completion of the questionnaire (IASTA Y-1) for both arms after the consultation and data collection Telephone call at 6 months with data collection on compliance with endometriosis monitoring
Objectives :
Primary objectives :
• Evaluate the effectiveness of virtual reality on anxiety in women with suspected endometriosis during the gynecological consultation.
Secondary objectives :
- Study the effect of virtual reality on compliance with endometriosis monitoring following the gynecological consultation
- Evaluate the effect of virtual reality on the pain felt during the gynecological examination
- Evaluate the level of satisfaction with the device during the session
Hypothesis :
- Null hypothesis (H0): No significant difference between groups on post-consultation anxiety scores after adjustment for pre-consultation anxiety scores
- Alternative hypothesis (H1): There is a significant difference between groups on post-consultation anxiety scores after adjustment for pre-consultation anxiety scores.
Inclusion criteria :
- Patient between 18 and 45 years old
- Patient referred for suspected endometriosis
- Patient consulting for the first time in the hospital
- Patient with first-line or second-line imaging documenting endometriosis (ultrasound or MRI)
- Patient agreeing to participate in the study and having signed informed consent
- Patient affiliated to a social security scheme
- Patient able to read and write French
Exclusion criteria:
- Patient with a history of major pelvic surgery for endometriosis
- Patient undergoing hysterectomy
- Virgin patient
- Pregnant woman
- Patient with psychiatric pathology
- Patient suffering from proven epilepsy
- Patient under judicial protection
- Patient under guardianship or curatorship
- Patient with visual or hearing impairment
- Patient with a progressive pathology responsible for chronic pain
Place of the study :
Intercommunal Hospital Center of Poissy Saint-Germain-En-Laye
Contact details :
Intercommunal Hospital Center of Poissy Saint-Germain-En-Laye Address: 10 rue du Champ Gaillard, 78300 Poissy Tel: +33139274581 Email: elise.lunelli@ght-yvelinesnord.fr
Speakers :
- Promoter: Intercommunal Hospital Center of Poissy Saint-Germain-En-Laye
- Coordinating investigator: Ms. Elise LUNELLI (registered nurse)
Funding :
GIRCI IDF and ARS IDF funding as part of the call for projects " Appel à projets recherche en soins (APRESO) "2024
Calendar :
Primary submission : 11/09/24 Secondary submission :26/09/24
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elise LUNELLI
- Phone Number: +33139274581
- Email: elise.lunelli@ght-yvelinesnord.fr
Study Locations
-
-
-
Poissy, France, 78300
- Recruiting
- Poissy-Saint Germain Hospital
-
Contact:
- Elise LUNELLI
- Phone Number: +33139274581
- Email: elise.lunelli@ght-yvelinesnord.fr
-
Principal Investigator:
- LUNELLI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Patient between 18 and 45 years old
- Patient referred for suspected endometriosis
- Patient consulting for the first time in the hospital
- Patient with first-line or second-line imaging documenting endometriosis (ultrasound or MRI)
- Patient agreeing to participate in the study and having signed informed consent
- Patient affiliated to a social security scheme
- Patient able to read and write French
Exclusion Criteria:
• Patient with a history of major pelvic surgery for endometriosis
- Patient undergoing hysterectomy
- Virgin patient
- Pregnant woman
- Patient with psychiatric pathology
- Patient suffering from proven epilepsy
- Patient under judicial protection
- Patient under guardianship or curatorship
- Patient with visual or hearing impairment
- Patient with a progressive pathology responsible for chronic pain
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Experimental Group A: The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes
|
The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes
|
|
No Intervention: group B
Group B control: The patient will be installed in a reception room and will be seated and wait for the doctor to arrive (no material)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants showing a reduction in post-consultation anxiety
Time Frame: Pre-consultation until post-consultation
|
Pre-consultation until post-consultation
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Arnaud FAUCONNIER, PROFESSOR, Pr FAUCONNIER
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-A01166-41
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.